You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 45 No. 9, September 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Peripheral Neuropathy Associated With Acquired Immunodeficiency Syndrome

Prevalence and Clinical Features From a Population-Based Survey

Yuen T. So, MD, PhD; David M. Holtzman, MD; Donald I. Abrams, MD; Richard K. Olney, MD

Arch Neurol. 1988;45(9):945-948.


Abstract

• We prospectively studied 40 hospitalized patients who had well-established diagnoses of acquired immunodeficiency syndrome. Patients with confounding risk factors for neuropathy were excluded; none of the study patients had known vitamin deficiency, alcoholism, or any metabolic, drug, or toxic factor. Clinical and electrophysiologic evidence of a distal symmetric polyneuropathy was found in 35% (13/37) of the patients. Symptoms and signs of neuropathy were usually mild, and painful dysesthesias were uncommon. Amplitude reduction of sural nerve action potentials distinguished all patients with from those without clinical neuropathy. Results of other electrophysiologic studies of sural, peroneal, and median nerves were typically normal. These results provide evidence of distal axonal degeneration. Neuropathy occurred only in patients with systemic illness longer than five months' duration. When compared with patients without neuropathy, these patients had more severe weight loss and a higher incidence of clinical dementia. Follow-up evaluation showed no evidence of clinical progression over a six-month period. The pathogenesis of this common distal axonal polyneuropathy is unknown and warrants further investigation.



Author Affiliations

From the Departments of Neurology (Drs So, Holtzman, and Olney) and Medicine (Dr Abrams), University of California San Francisco.


Footnotes

Accepted for publication April 12, 1988.

Reprint requests to Department of Neurology, M 794, University of California San Francisco, Parnassus Avenue, San Francisco, CA 94143 (Dr So).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Genome-Wide Screen Identifies Drug-Induced Regulation of the Gene Giant Axonal Neuropathy (Gan) in a Mouse Model of Antiretroviral-Induced Painful Peripheral Neuropathy
Dorsey et al.
Biol Res Nurs 2009;11:7-16.
ABSTRACT  

Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda
Sacktor et al.
Neurology 2009;72:165-170.
ABSTRACT | FULL TEXT  

Cannabis in painful HIV-associated sensory neuropathy: A randomized placebo-controlled trial
Abrams et al.
Neurology 2007;68:515-521.
ABSTRACT | FULL TEXT  

Specific Neurologic Complications of Human Immunodeficiency Virus Type 1 (HIV-1) Infection in Children
Wilmshurst et al.
J Child Neurol 2006;21:788-794.
ABSTRACT  

Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort
Cherry et al.
Neurology 2006;66:867-873.
ABSTRACT | FULL TEXT  

Human Immunodeficiency Virus-Associated Peripheral Neuropathies
Ferrari et al.
Mayo Clin Proc. 2006;81:213-219.
ABSTRACT | FULL TEXT  

Evaluation of a clinical screening tool for HIV-associated sensory neuropathies
Cherry et al.
Neurology 2005;65:1778-1781.
ABSTRACT | FULL TEXT  

Lentivirus Infection Causes Neuroinflammation and Neuronal Injury in Dorsal Root Ganglia: Pathogenic Effects of STAT-1 and Inducible Nitric Oxide Synthase
Zhu et al.
J. Immunol. 2005;175:1118-1126.
ABSTRACT | FULL TEXT  

Anti-sulfatide antibodies in HIV-infected individuals with sensory neuropathy
Lopate et al.
Neurology 2005;64:1632-1634.
ABSTRACT | FULL TEXT  

Markers of immune activation and viral load in HIV-associated sensory neuropathy
Schifitto et al.
Neurology 2005;64:842-848.
ABSTRACT | FULL TEXT  

Incidence of and risk factors for HIV-associated distal sensory polyneuropathy
Schifitto et al.
Neurology 2002;58:1764-1768.
ABSTRACT | FULL TEXT  

Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy
Schifitto et al.
Neurology 2001;57:1313-1316.
ABSTRACT | FULL TEXT  

Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART)
Maschke et al.
J. Neurol. Neurosurg. Psychiatry 2000;69:376-380.
ABSTRACT | FULL TEXT  

Distal Sensory Polyneuropathy in a Cohort of HIV-Infected Children Over Five Years of Age
Araújo et al.
Pediatrics 2000;106:35e-35.
ABSTRACT | FULL TEXT  

Autonomic Performance and Dehydroepiandrosterone Sulfate Levels in HIV-1-Infected Individuals: Relationship to TH1 and TH2 Cytokine Profile
Schifitto et al.
Arch Neurol 2000;57:1027-1032.
ABSTRACT | FULL TEXT  

The role of somatosensory evoked potentials in the diagnosis of AIDS-associated myelopathy
Tagliati et al.
Neurology 2000;54:1477-1482.
ABSTRACT | FULL TEXT  

A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection
McArthur et al.
Neurology 2000;54:1080-1088.
ABSTRACT | FULL TEXT  

Peripheral Nerve Function in HIV Infection: Clinical, Electrophysiologic, and Laboratory Findings
Tagliati et al.
Arch Neurol 1999;56:84-89.
ABSTRACT | FULL TEXT  

Acupuncture and Amitriptyline for Pain Due to HIV-Related Peripheral Neuropathy: A Randomized Controlled Trial
Shlay et al.
JAMA 1998;280:1590-1595.
ABSTRACT | FULL TEXT  

The Impact of Neurologic Disease on Hospitalizations Related to Human Immunodeficiency Virus Infection in Maryland, 1991-1992
Pan et al.
Arch Neurol 1997;54:846-852.
ABSTRACT  

Effect of Nucleoside Analogs on Neurite Regeneration and Mitochondrial DNA Synthesis in PC-12 Cells
Cui et al.
J. Pharmacol. Exp. Ther. 1997;280:1228-1234.
ABSTRACT | FULL TEXT  

Human Immunodeficiency Virus--Associated Motor Axonal Polyradiculoneuropathy
Goldstein et al.
Arch Neurol 1993;50:1316-1319.
ABSTRACT  

Peripheral Nervous System Involvement in a Large Cohort of Human Immunodeficiency Virus--Infected Individuals
Barohn et al.
Arch Neurol 1993;50:167-171.
ABSTRACT  

Transmission of Human Immunodeficiency Virus in a Dental Practice
Ciesielski et al.
ANN INTERN MED 1992;116:798-805.
ABSTRACT  

Peripheral Neuropathy in a Cohort of Human Immunodeficiency Virus--Infected Patients: Incidence and Relationship to Other Nervous System Dysfunction
Hall et al.
Arch Neurol 1991;48:1273-1274.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.